Taysha Gene Therapies's market cap is currently $332.01M. The company's EPS TTM is $-0.033; its P/E ratio is ―; Taysha Gene Therapies is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 15.45M	$ 2.50M	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 15.45M	$ 15.00K	$ -492.00K	$ -9.00K	$ 0.00
Operating Income	$ -72.44M	$ -162.45M	$ -173.27M	$ -43.00M	$ -1.11M
EBITDA	$ -105.20M	$ -159.73M	$ -172.78M	$ -42.99M	$ 0.00
Net Income	$ -111.57M	$ -169.58M	$ -175.46M	$ -43.00M	$ -1.11M
Balance Sheet
Cash & Short-Term Investments	$ 143.94M	$ 87.88M	$ 149.10M	$ 251.25M	$ 0.00
Total Assets	$ 172.73M	$ 126.28M	$ 213.96M	$ 258.88M	$ 15.00K
Total Debt	$ 61.11M	$ 59.93M	$ 63.09M	$ 0.00	$ 0.00
Net Debt	$ -82.83M	$ -27.95M	$ -86.01M	$ -251.25M	$ 0.00
Total Liabilities	$ 97.79M	$ 125.33M	$ 118.57M	$ 7.58M	$ 150.00K
Stockholders' Equity	$ 74.94M	$ 949.00K	$ 95.38M	$ 251.30M	$ -135.00K
Cash Flow
Free Cash Flow	$ -80.39M	$ -113.26M	$ -138.60M	$ -39.81M	$ 135.00K
Operating Cash Flow	$ -73.02M	$ -88.39M	$ -117.04M	$ -30.73M	$ 135.00K
Investing Cash Flow	$ -7.35M	$ -24.93M	$ -21.55M	$ -9.08M	$ 0.00
Financing Cash Flow	$ 136.39M	$ 52.10M	$ 39.08M	$ 291.06M	$ 0.00

Currency in USD

Taysha Gene Therapies Earnings and Revenue History

Income Statement >

Taysha Gene Therapies Debt to Assets

Balance Sheet >

Taysha Gene Therapies Cash Flow

Cash Flow >

Taysha Gene Therapies Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing